Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

LBG Media finance chief permanently steps down

(Sharecast News) - Online content publisher LBG Media confirmed on Thursday that chief financial officer Richard Jarvis has stepped down and left the business with immediate effect. The AIM-traded firm said Jarvis had previously taken time away from the company for personal reasons, as it announced on 22 January.

Executive chair Dave Wilson, who took on his role last month with a focus on supporting the finance and legal teams, would continue to oversee financial operations while the company searched for a new CFO.

The board said Wilson already had extensive financial and legal experience, having spent 14 years in senior roles at GB Group.

LBG said it had initiated the process to appoint a new CFO, and would provide updates in due course.

"I would like to thank Richard for his commitment and support," said group chief executive officer Solly Solomou.

"Richard has led important initiatives to build the finance and legal functions that will support our long-term growth ambitions and I wish him well for the future."

At 1531 GMT, shares in LBG Media were down 7.83% at 106p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.